Alkaloids Chem Biol
10.3390/MOLECULES27010167 170 ShiX.XiangS.CaoJ.ZhuH.YangB.HeQ.et al (2019)
Kaloryczno dobierana jest indywidualnie, w zalenoci od masy ciaa, poziomu aktywnoci i potrzeb organizmu
Several large-scale cardiovascular outcome trials (including LEADER, SUSTAIN-6, and REWIND) have shown that certain GLP-1 receptor agonists liraglutide, semaglutide, and dulaglutide reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in people with established cardiovascular disease or multiple cardiovascular risk factors
What do randomized controlled trials of high-dose daily vitamin B12 supplementation show about the effects on cancer risk, death, and longevity
It is the most common reason